We found that both PAK1/2 inhibitors robustly decreased RAS T148 phosphorylation in MM cells treated with MG-132, whereas the MTOR inhibitor AZD-8055 had a more muted effect on T148 phosphorylation (Fig. 6E). This evidence concerns the gene PAK1 and Miyoshi myopathy.